Session I: September 7, 2022

Understanding and Addressing the Impact of COVID-19 on the Prostate Cancer Racial Disparity

During the COVID-19 pandemic, prostate cancer early detection screenings and treatments were delayed. This session will examine how Black patients were impacted as compared to other patients. It will also examine the challenges faced today in catching up while handling the dramatic increase in the number of new prostate cancer cases estimated by the American Cancer Society (ACS). The ACS estimated a 30% increase in new prostate cancer cases in 2021 and an additional 8% increase in 2022 with 268,490 new cases in 2022 alone. This is the largest increase in new cases for any of the four major cancers.

Prior Summit Images

Welcome and Opening RemarksMr. Thomas Farrington, President and Founder, PHEN   Watch Video

RemarksCongressman Gregory W. Meeks (D5-NY)    Watch Video

Moderator: J. Jacques Carter, MD, MPH, Assistant Professor of Medicine, Harvard Medical School    Watch Video

Prostate Cancer New Cases Overview from American Cancer Society (ACS)

Keith Crawford, MD, PhD, Director of Clinical Trials and Patient Education, PHEN    Watch Video

An Assessment of Prostate Cancer Treatment Among Black and White Patients During the COVID-19 Pandemic

Adrien Bernstein, MD, MS, Urologic Oncologist, Albany Medical College, Albany, NY    Watch Video

Racial Disparities in Prostate Specific Antigen Screening and Referral to Urology in a Large, Integrated Health Care System: A Retrospective Cohort Study – Review of findings

David Vasir, PhD, Senior Research Analyst, PHEN    Watch Video

Panel Discussion with Q&A:    Watch Video

The session presenters will be joined on the panel by other leaders to discuss the impact of the COVID-19 pandemic on the prostate cancer racial disparity, and the challenges to move progress forward towards eliminating the disparity.

Richard Lee, MD, PhD, Medical Oncologist, Massachusetts General Hospital

Angelo Moore, PhD, RN, Assistant Director of Community Outreach, Engagement and Equity, Duke Cancer Institute

Wendy Poage, MHA, President, Prostate Conditions Education Council (PCEC)

Jsaela Barrow MPH, Advocacy Coordinator, American Urological Association (AUA)

Thaddeus Bell, MD, Prostate Cancer Survivor / Family Doctor, Founder of Closing The Gap in Healthcare

Mr. Dave Ford, Prostate Cancer Survivor, Senior Manager at Southern California Edison and Board Member of American Cancer Society

Closing Remarks: Mr. Thomas Farrington


PHEN thanks its sponsors for their invaluable support of the 2022 Summit.